Your browser doesn't support javascript.
loading
Controlled release, antimicrobial activity, and oral mucosa irritation of cetylpyridinium chloride-montmorillonite incorporated in a tissue conditioner.
Asahara, Erika; Abe, Yasuhiko; Nakamori, Kiichi; Okazaki, Yohei; Makita, Yoji; Hasebe, Akira; Tsuga, Kazuhiro; Yokoyama, Atsuro.
Affiliation
  • Asahara E; Department of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Abe Y; Department of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Nakamori K; Department of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Okazaki Y; Department of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Makita Y; Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST).
  • Hasebe A; Oral Molecular Microbiology, Department of Oral Pathobiological Science, Faculty and Graduate School of Dental Medicine, Hokkaido University.
  • Tsuga K; Department of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Yokoyama A; Oral Functional Prosthodontics, Department of Oral Functional Science, Faculty and Graduate School of Dental Medicine, Hokkaido University.
Dent Mater J ; 41(1): 142-149, 2022 Feb 01.
Article in En | MEDLINE | ID: mdl-34556596
ABSTRACT
This study examined the controlled release of cetylpyridinium chloride (CPC) from a tissue conditioner (TC) containing CPC-montmorillonite (CPC-Mont), the associated antimicrobial activity, and oral mucosa irritation. The CPC release test was performed daily for 28 days in three test solutions distilled water, 0.2 M NaCl, and 0.2 M HCl. The antimicrobial activities for 7, 14, 21, and 28 days against Candida albicans, Staphylococcus aureus, and Streptococcus mutans were assessed according to the JIS Z 2801/ISO 22196 standard. An oral mucosa irritation test was conducted using cheek pouches in five male hamsters according to the ISO 10993-102010 standard. The amount of CPC released each day and the cumulative amount released over 28 days (6.12 mg) were less than the daily safe maximum of sore throat medicines (8 mg). Additionally, TC with CPC-Mont could sustain antimicrobial activity against adherent bacteria for 14 days and has no oral mucosa irritation potential.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cetylpyridinium / Anti-Infective Agents, Local Limits: Humans / Male Language: En Journal: Dent Mater J Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cetylpyridinium / Anti-Infective Agents, Local Limits: Humans / Male Language: En Journal: Dent Mater J Year: 2022 Document type: Article
...